Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Magnesium Oxide for Hot Flashes in Cancer Patients
NCT01008904Phase 2Completed
- Sponsor
- Virginia Commonwealth University
- Start
- Jul 2009
- Primary completion
- Jan 2013
- Modality
- Orthosteric Ligands
01
Overview
Phase 2, open-label, single-arm trial of magnesium oxide in hot flashes, sponsored by Virginia Commonwealth University. Primary endpoint: Percent Difference in Hot Flash Activity (Score) Between Baseline and End of Treatment at 5 weeks. Started Jul 2009; status: completed.
02
Drugs
magnesium oxide
03
Conditions
hot flashes
Beyond the preview
Go deeper on NCT01008904.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01008904.